osimertinib
astrazeneca
['osimertinib']
 i am with you here. i do not think that we have proven yet that improved survival on adjuvant osi equals increased cures. delayed recurrences are common in this population. imo increased survival is undeniable and is a basis for using osimertinib.
Medical oncologist specializing in lung cancer at UC San Diego. Multitasker. Love audiobooks.